Not "we" need to see it in action. "They" need to see it in action. Did you not read the shareholder letter from the 8th?
Again this is all my speculation but with the events it makes sense. As I speculated the day the letter came out the underwriting referenced was going to be dillution of shares to raise capital to start LTC production. The 25 million OS share increase seems to align with this idea.
Lowman's post regarding Dr. Kutz's trip to the Ukraine again reinforces the idea that this new management team is going to be coming aboard following that trip as that would be the last step in their DD regarding to the deal.
My guess is that part or all of that new 25 million shares is going to this management team, either as a purchase to infuse the cash for production, or as compensation for them starting production. I imagine we'll see a PR/8-K once the deal is complete following the trip where we'll find out the structure of the deal and exactly who the mystery management team is.
If anyone else is reading this differently feel free to comment. I am more than open to hearing other ideas on what is going on.
ref: "To that end, we are in discussions with a prospective underwriter that has assisted the Company in the past concerning the raising of sufficient funds to pay current liabilities and to cover operating expenses during the ramp-up and initial stage of sales and marketing for LTC. In addition, we are also in discussions with a prospective management team with which Don Robbins had been negotiating to execute a plan to commercialize LTC’s technology. Assuming that we are successful in concluding those negotiations we will accompany two members of this prospective management team to complete the due diligence by travelling to Ukraine later this month, accompanied by Dr. Kutz and Herman Hohauser, to witness a number of procedures on live patients performed by Ukrainian surgeons"
